Stevens Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-452
Closed -$475K 370
2024
Q3
$475K Buy
+452
New +$475K 0.07% 120
2024
Q1
Sell
-418
Closed -$367K 345
2023
Q4
$367K Buy
+418
New +$367K 0.09% 184
2023
Q2
Sell
-1,008
Closed -$828K 297
2023
Q1
$828K Buy
1,008
+230
+30% +$189K 0.21% 71
2022
Q4
$561K Sell
778
-73
-9% -$52.6K 0.35% 49
2022
Q3
$586K Buy
851
+152
+22% +$105K 0.38% 49
2022
Q2
$413K Buy
+699
New +$413K 0.29% 59
2022
Q1
Sell
-4,407
Closed -$2.78M 294
2021
Q4
$2.78M Buy
4,407
+1,745
+66% +$1.1M 0.64% 41
2021
Q3
$1.61M Buy
+2,662
New +$1.61M 0.68% 34
2021
Q2
Sell
-427
Closed -$202K 222
2021
Q1
$202K Buy
+427
New +$202K 0.11% 117
2020
Q4
Sell
-18,098
Closed -$10.1M 212
2020
Q3
$10.1M Buy
+18,098
New +$10.1M 3.76% 5
2019
Q4
Sell
-3,283
Closed -$911K 764
2019
Q3
$911K Sell
3,283
-28,955
-90% -$8.03M 0.08% 245
2019
Q2
$10.1M Buy
32,238
+31,519
+4,384% +$9.86M 0.45% 50
2019
Q1
$295K Buy
+719
New +$295K 0.01% 577
2018
Q1
Sell
-18,613
Closed -$7M 944
2017
Q4
$7M Buy
+18,613
New +$7M 0.27% 115
2016
Q3
Sell
-7,364
Closed -$2.57M 1105
2016
Q2
$2.57M Buy
+7,364
New +$2.57M 0.1% 254
2016
Q1
Sell
-15,022
Closed -$8.16M 1069
2015
Q4
$8.16M Buy
15,022
+9,736
+184% +$5.29M 0.32% 90
2015
Q3
$2.46M Buy
+5,286
New +$2.46M 0.11% 198
2014
Q3
Sell
-50,749
Closed -$14.3M 1207
2014
Q2
$14.3M Buy
+50,749
New +$14.3M 0.38% 69
2014
Q1
Sell
-25,429
Closed -$7M 1274
2013
Q4
$7M Buy
+25,429
New +$7M 0.21% 129
2013
Q3
Sell
-21,937
Closed -$4.93M 1179
2013
Q2
$4.93M Buy
+21,937
New +$4.93M 0.16% 169